John has been covering financial markets since before the FTSE 100 existed, starting out on the Industries and Commodities team at Dun & Bradstreet, before moving on to Datastream, where he was head of the news team for several years. After a succession of management roles at Thomson Reuters he returned to front-line journalism in 2006. Prior to joining Proactive Investors he was managing editor at Sharecast.
One's a weight loss drug, the other deals with female sexual desire disorder. The potential market sizes for both are absolutely enormous.
OptiBiotix will develop and supply multiple consumer products containing LPldl to Pharmabiota to be sold through the latter's extensive antipodean partner network
Through its 91%-owned subsidiaries, Alternative Medicine Association and Infused, the company owns and operates a licensed medical and adult use marijuana cultivation and production facility in Las Vegas
Nevada legalized the purchase of marijuana for recreational use at the beginning of July and sales have been strong
Motif was spun out of Amphion in April 2015. Amphion remains a major shareholders.
Half-year revenues were up 13.5% from a year earlier, keeping things ticking higher as the company focused on its licence agreement with CRISPR.
Infectious Diseases is a global conference attended by more than 6,000 healthcare professionals practicing or involved in infectious diseases
EuropaColon works with 43 groups across 32 European countries and has been recognized as the voice of colorectal cancer patients in Europe
Seeing as the ideas behind the virtual portfolio were largely lifted wholesale from Miton's Gervais Williams, its inclusion is apposite
The high-yield portfolio is up 8.8% over a five month period - and that's ignoring the juicy dividends
The spreads on some of the shares identified by the stock screen were wider than the flares I wore in the seventies
With a bid/offer spread of 20%, the share price of clean water technology company HaloSource had better be scintillating